Tyler Jacks

Director/Board Member at THERMO FISHER SCIENTIFIC, INC.

Net worth: 11 M $ as of 2026-01-30

65 year

96 connections

Consumer Services

Health Technology

Finance

Profile

Tyler E.
Jacks is the founder of T2 Biosystems, Inc. (2006) and Dragonfly Therapeutics, Inc. (2016).
Current jobs include Independent Director at Amgen, Inc. (2012), Director at Thermo Fisher Scientific, Inc. (2009), President & Director at Commonwealth Cancer Consortium, Inc. (2021), and Professor at Massachusetts Institute of Technology (2007).
Former jobs include Chairman at National Cancer Institute and Director at David H.
Koch Institute for Integrative Cancer Research (2001-2021).
Education includes an undergraduate degree from Harvard University (1983) and a doctorate from The University of California, San Francisco (1988).

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
AMGEN INC. 0%	2025-05-22	17,193 ( 0% )	6 M $	2026-01-30
THERMO FISHER SCIENTIFIC INC. 0%	2025-05-20	8,963 ( 0% )	5 M $	2026-01-30

Tyler Jacks active positions

Companies	Position	Start
THERMO FISHER SCIENTIFIC, INC.	Director/Board Member	2009-05-25
AMGEN INC.	Director/Board Member	2011-12-31
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Corporate Officer/Principal	2006-12-31
Commonwealth Cancer Consortium, Inc. Commonwealth Cancer Consortium, Inc. Operates as a nonprofit cancer research foundation	President	2021-01-31

All active positions of Tyler Jacks

Former positions of Tyler Jacks

Companies	Position	End
David H. Koch Institute for Integrative Cancer Research David H. Koch Institute for Integrative Cancer Research Operates as cancer research center	Director/Board Member	2020-12-31
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research	Chairman	2015-12-31
T2 BIOSYSTEMS, INC.	Founder	2012-12-31
Dragonfly Therapeutics, Inc. Dragonfly Therapeutics, Inc. Develops therapy to stimulate immune responses against cancer	Founder	-

See the detail of Tyler Jacks's experience

Training of Tyler Jacks

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tyler Jacks's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Amgen, Inc. Amgen, Inc. Discovers, develops, manufactures and delivers human therapeutics
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
The University of California, San Francisco The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research	Miscellaneous
Thermo Fisher Scientific, Inc. Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments	Health Technology
T2 Biosystems, Inc. T2 Biosystems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products	Health Technology
David H. Koch Institute for Integrative Cancer Research David H. Koch Institute for Integrative Cancer Research Operates as cancer research center
Dragonfly Therapeutics, Inc. Dragonfly Therapeutics, Inc. Develops therapy to stimulate immune responses against cancer
Commonwealth Cancer Consortium, Inc. Commonwealth Cancer Consortium, Inc. Operates as a nonprofit cancer research foundation